VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $786,609 | -7.1% | 29,231 | +4.0% | 0.36% | -18.5% |
| Q2 2023 | $846,305 | +1559.4% | 28,107 | +1216.5% | 0.44% | +1309.7% |
| Q3 2022 | $51,000 | -23.9% | 2,135 | -12.9% | 0.03% | -16.2% |
| Q2 2022 | $67,000 | +97.1% | 2,452 | +179.0% | 0.04% | +146.7% |
| Q1 2022 | $34,000 | +21.4% | 879 | 0.0% | 0.02% | +25.0% |
| Q4 2021 | $28,000 | +7.7% | 879 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $26,000 | -13.3% | 879 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $30,000 | +7.1% | 879 | +0.3% | 0.02% | 0.0% |
| Q1 2021 | $28,000 | 0.0% | 876 | +11.0% | 0.02% | -22.7% |
| Q4 2020 | $28,000 | +47.4% | 789 | +53.5% | 0.02% | +22.2% |
| Q3 2020 | $19,000 | – | 514 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |